PDCD1 and neoplasm: The binding of PD-L1 to the inhibitory checkpoint molecule PD-1, found on activated T cells, B cells, and myeloid cells, results in anergy and apoptosis of T cells and thus helps the tumor cells to evade the antitumor immunity [73].